221 related articles for article (PubMed ID: 17525716)
41. Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients.
Kim HW; Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
Nephrology (Carlton); 2009 Oct; 14(7):681-8. PubMed ID: 19796028
[TBL] [Abstract][Full Text] [Related]
42. Haptoglobin: function and polymorphism.
Wassell J
Clin Lab; 2000; 46(11-12):547-52. PubMed ID: 11109501
[TBL] [Abstract][Full Text] [Related]
43. Vitamin E and diabetic nephropathy in mice model and humans.
Farid N; Inbal D; Nakhoul N; Evgeny F; Miller-Lotan R; Levy AP; Rabea A
World J Nephrol; 2013 Nov; 2(4):111-24. PubMed ID: 24255894
[TBL] [Abstract][Full Text] [Related]
44. Association of the genetic variant rs2000999 with haptoglobin and diabetic macrovascular diseases in Chinese patients with type 2 diabetes.
Wang S; Zhang R; Wang T; Jiang F; Hu C; Jia W
J Diabetes Complications; 2019 Feb; 33(2):178-181. PubMed ID: 30366827
[TBL] [Abstract][Full Text] [Related]
45. Poor lysosomal membrane integrity in proximal tubule cells of haptoglobin 2-2 genotype mice with diabetes mellitus.
Asleh R; Nakhoul FM; Miller-Lotan R; Awad H; Farbstein D; Levy NS; Nakhoul N; Iancu TC; Manov I; Laue M; Traber MG; Lebold KM; Levy AP
Free Radic Biol Med; 2012 Aug; 53(4):779-86. PubMed ID: 22749805
[TBL] [Abstract][Full Text] [Related]
46. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
[TBL] [Abstract][Full Text] [Related]
47. Haptoglobin: a review of the major allele frequencies worldwide and their association with diseases.
Carter K; Worwood M
Int J Lab Hematol; 2007 Apr; 29(2):92-110. PubMed ID: 17474882
[TBL] [Abstract][Full Text] [Related]
48. Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.
Costacou T; Secrest AM; Ferrell RE; Orchard TJ
Diab Vasc Dis Res; 2014 Sep; 11(5):335-42. PubMed ID: 24994788
[TBL] [Abstract][Full Text] [Related]
49. Haptoglobin genotypes in Chagas' disease.
Jorge SE; Abreu CF; Guariento ME; Sonati Mde F
Clin Biochem; 2010 Feb; 43(3):314-6. PubMed ID: 19804773
[TBL] [Abstract][Full Text] [Related]
50. Interaction between haptoglobin genotype and glycemic variability on diabetic macroangiopathy: a population-based cross-sectional study.
Deng Z; Wang S; Lu J; Zhang R; Zhang L; Lu W; Zhu W; Bao Y; Zhou J; Hu C
Endocrine; 2023 Nov; 82(2):311-318. PubMed ID: 37615814
[TBL] [Abstract][Full Text] [Related]
51. Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients.
Lajer M; Tarnow L; Jorsal A; Parving HH
Nephrol Dial Transplant; 2007 Nov; 22(11):3235-9. PubMed ID: 17567649
[TBL] [Abstract][Full Text] [Related]
52. The 20210 G to A prothrombin polymorphism and late complications in type 1 diabetes mellitus.
Humpert PM; Isermann B; Rudofsky G; Ziegler R; Bierhaus A; Ritz E; Nawroth PP
Thromb Haemost; 1999 Jan; 81(1):164. PubMed ID: 10348712
[No Abstract] [Full Text] [Related]
53. Haptoglobin levels are associated with haptoglobin genotype and alpha+ -Thalassemia in a malaria-endemic area.
Imrie H; Fowkes FJ; Michon P; Tavul L; Hume JC; Piper KP; Reeder JC; Day KP
Am J Trop Med Hyg; 2006 Jun; 74(6):965-71. PubMed ID: 16760505
[TBL] [Abstract][Full Text] [Related]
54. Haptoglobin phenotype and coronary artery collaterals in diabetic patients.
Hochberg I; Roguin A; Nikolsky E; Chanderashekhar PV; Cohen S; Levy AP
Atherosclerosis; 2002 Apr; 161(2):441-6. PubMed ID: 11888529
[TBL] [Abstract][Full Text] [Related]
55. Association of VEGF-1499C-->T polymorphism with diabetic nephropathy in type 1 diabetes mellitus.
McKnight AJ; Maxwell AP; Patterson CC; Brady HR; Savage DA
J Diabetes Complications; 2007; 21(4):242-5. PubMed ID: 17616354
[TBL] [Abstract][Full Text] [Related]
56. The DG10S478 variant in the TCF7L2 gene is not associated with microvascular complications in type 2 diabetes.
Buchbinder S; Rudofsky G; Humpert PM; Schilling T; Zorn M; Bierhaus A; Nawroth PP
Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):211-4. PubMed ID: 18072015
[TBL] [Abstract][Full Text] [Related]
57. Structure-function analysis of the antioxidant properties of haptoglobin.
Melamed-Frank M; Lache O; Enav BI; Szafranek T; Levy NS; Ricklis RM; Levy AP
Blood; 2001 Dec; 98(13):3693-8. PubMed ID: 11739174
[TBL] [Abstract][Full Text] [Related]
58. Identification of a xylosyltransferase II gene haplotype marker for diabetic nephropathy in type 1 diabetes.
Hendig D; Tarnow L; Kuhn J; Kleesiek K; Götting C
Clin Chim Acta; 2008 Dec; 398(1-2):90-4. PubMed ID: 18789912
[TBL] [Abstract][Full Text] [Related]
59. Haptoglobin genotype and endothelial function in diabetes mellitus: a pilot study.
Dayan L; Levy AP; Blum S; Miller-Lotan R; Melman U; Alshiek J; Jacob G
Eur J Appl Physiol; 2009 Jul; 106(4):639-44. PubMed ID: 19347351
[TBL] [Abstract][Full Text] [Related]
60. Concomitant macro and microvascular complications in diabetic nephropathy.
Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
